294 related articles for article (PubMed ID: 32939568)
1. Variation of red blood cell parameters in Behcet's disease: association with disease severity and vascular involvement.
Cheng L; Li L; Liu C; Yan S; Chen H; Li H; Zhang F; Chen H; Li Y
Clin Rheumatol; 2021 Apr; 40(4):1457-1464. PubMed ID: 32939568
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of diagnostic performance of haematological parameters in Behçet's disease.
Tezcan D; Körez MK; Gülcemal S; Hakbilen S; Akdağ T; Yılmaz S
Int J Clin Pract; 2021 Oct; 75(10):e14638. PubMed ID: 34309974
[TBL] [Abstract][Full Text] [Related]
3. Haematological, biochemical and inflammatory parameters in inactive Behçet's disease. Its association with red blood cell distribution width.
Vayá A; Rivera L; Todolí J; Hernandez JL; Laiz B; Ricart JM
Clin Hemorheol Microcirc; 2014; 56(4):319-24. PubMed ID: 23719420
[TBL] [Abstract][Full Text] [Related]
4. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet's disease patients receiving immunomodulatory treatment.
Cheng L; Li Y; Wu Z; Li L; Liu C; Liu J; Dai J; Zheng W; Zhang F; Tang L; Yu X; Li Y
BMC Immunol; 2021 Feb; 22(1):16. PubMed ID: 33618671
[TBL] [Abstract][Full Text] [Related]
6. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease.
Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM
Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148
[TBL] [Abstract][Full Text] [Related]
7. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
9. Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.
Bassyouni IH; El-Wakd MM; Bassyouni RH
J Clin Immunol; 2013 Feb; 33(2):361-7. PubMed ID: 23097037
[TBL] [Abstract][Full Text] [Related]
10. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
Ataş H; Canpolat F; Eskioglu F
Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
[TBL] [Abstract][Full Text] [Related]
12. Relation of erythrocyte and iron indices to oral cancer growth.
Bhattathiri VN
Radiother Oncol; 2001 May; 59(2):221-6. PubMed ID: 11325453
[TBL] [Abstract][Full Text] [Related]
13. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome.
Zhang Z; Gao S; Dong M; Luo J; Xu C; Wen W; Huang Y; Wu Y; Zhou J; Yuan Z
Dis Markers; 2022; 2022():2193343. PubMed ID: 36393972
[TBL] [Abstract][Full Text] [Related]
15. Mean platelet volume in bipolar disorder: the search for an ideal biomarker.
Mert DG; Terzi H
Neuropsychiatr Dis Treat; 2016; 12():2057-62. PubMed ID: 27578978
[TBL] [Abstract][Full Text] [Related]
16. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: A meta-analysis.
Lee YH; Song GG
Int J Rheum Dis; 2018 Dec; 21(12):2180-2187. PubMed ID: 30417545
[TBL] [Abstract][Full Text] [Related]
18. Platelet Activation in Ocular Behçet's Patients with Posterior Segment Involvement.
Citirik M; Ozdal PC; Keles A; Haznedaroglu IC
Middle East Afr J Ophthalmol; 2021; 28(4):203-207. PubMed ID: 35719287
[TBL] [Abstract][Full Text] [Related]
19. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
20. Improving the diagnosis of myelodysplastic syndrome by red blood cell parameters.
Zhu Y; Han S; Chen X; Wu S; Xiong B
Clin Transl Oncol; 2023 Oct; 25(10):2983-2990. PubMed ID: 37081223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
